Potential Treatment to slow down Parkinson’s disease

Adrian In Brief, Industry Focus, Innovations, Life Sciences & Pharma, Opinion and Analysis 0 Comments

University of Sheffield scientists have discovered that a drug that has been in use for a long time to treat liver disease could be effective in slowing down the progression of Parkinson’s disease. Published in Neurology, the study demonstrated the benficial effects of UDCA on the nerve cells affected in Parkinson’s disease. It is encouraging that, even at low concentrations …

Autism and Asperger’s Syndrome – Infographic

Adrian Industry Focus, Life Sciences & Pharma, Opinion and Analysis 0 Comments

This Infographic provides some key facts and figures about Autism and Asperger’s Syndrome, and also dispels a few myths. I have produced it from information provided by the CDC, autism.org.uk, autism-society.org and commentary by Dr Russell of Exeter University, UK. As you can see, there has been a continuous rise in the number of children diagnosed with autism, in recent …

Food and Drug Administration

Clearing the way for Personalised Medicine

Adrian Life Sciences & Pharma, Opinion and Analysis, US Economy 1 Comment

Introduction In “Ride the Wave”, Fred Rogers and Richard Lalich point to the huge potential of personalised medicine based on bio-information. Knowledge of the gentic make-up of an individual will soon allow us to cure many of the maladies that afflict us – and maybe even slow down the rate at which we age. As you will see, this will …